| Analysts were expecting Integra LifeSciences Holdings Corp. (IART) [Chart - News - Analysis] to report earnings of $0.52 for last quarter, but IART beat expectations with actual earnings of $0.53---1 cent above the consensus estimate. IART also issued earnings guidance for next quarter that is in line with current analyst expectations. If you compare last quarter's earnings to the $0.46 the company made per share during the same quarter a year ago, you can see that IART’s earnings are up this year. {loadposition link_newslink1} | {loadposition livevideopromo} | | | | | | {loadposition homeaccordion2} | | | {loadposition contentad} | | | | | | | | Also, if you compare IART's 15.75% projected earnings-per-share (EPS) growth rate for the next five years with the projected EPS growth rate of 13.25% for the Medical Instruments & Supplies industry as a whole during that same time frame, you can see that analysts expect IART to outperform the industry in the future---which is a good sign for the stock. Drilling down a little deeper into the Medical Instruments & Supplies industry, you can see how analysts believe IART will stack up against some of the other stocks in the industry, like Stryker Corp. (SYK) [Chart - News - Analysis] and DENTSPLY International Inc. (XRAY) [Chart - News - Analysis], in the future. Analysts believe SYK's earnings are going to grow at a rate of 12.10% while XRAY's earnings are going to grow at a rate of 8.00%. Earnings season can be a volatile time in the stock market. Check out these videos and articles to be better prepared to take advantage of the large price moves that tend to accompany earnings announcements. - Earnings Season is Here - Find Out How to Trade It - Using Options to Trade Earnings - Understanding Stock Analyst Research and Recommendations {loadposition link_nowtime} {loadposition followus} | 
